
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Gemcitabine in Recurrent Meningioma
Satvik Khaddar, Arti Bhelekar, Ochin Dale, et al.
South Asian Journal of Cancer (2020) Vol. 09, Iss. 04, pp. 261-261
Open Access | Times Cited: 4
Satvik Khaddar, Arti Bhelekar, Ochin Dale, et al.
South Asian Journal of Cancer (2020) Vol. 09, Iss. 04, pp. 261-261
Open Access | Times Cited: 4
Showing 4 citing articles:
Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas
Gerhard Jungwirth, Tao Yu, Fang Liu, et al.
Clinical Cancer Research (2022) Vol. 29, Iss. 1, pp. 233-243
Open Access | Times Cited: 13
Gerhard Jungwirth, Tao Yu, Fang Liu, et al.
Clinical Cancer Research (2022) Vol. 29, Iss. 1, pp. 233-243
Open Access | Times Cited: 13
Gemcitabine radiosensitization primes irradiated malignant meningioma cells for senolytic elimination by navitoclax
Masahiro Yamamoto, Tomomi Sanomachi, Shuhei Suzuki, et al.
Neuro-Oncology Advances (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 14
Masahiro Yamamoto, Tomomi Sanomachi, Shuhei Suzuki, et al.
Neuro-Oncology Advances (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 14
Gemcitabine Cooperates with Everolimus to Inhibit the Growth of and Sensitize Malignant Meningioma Cells to Apoptosis Induced by Navitoclax, an Inhibitor of Anti-Apoptotic BCL-2 Family Proteins
Masahiro Yamamoto, Shuhei Suzuki, Keita Togashi, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1706-1706
Open Access | Times Cited: 7
Masahiro Yamamoto, Shuhei Suzuki, Keita Togashi, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1706-1706
Open Access | Times Cited: 7
Will mastering ferroptosis allow treating refractory meningiomas?
Christine Marosi
Neuro-Oncology (2021) Vol. 23, Iss. 12, pp. 1989-1990
Open Access | Times Cited: 2
Christine Marosi
Neuro-Oncology (2021) Vol. 23, Iss. 12, pp. 1989-1990
Open Access | Times Cited: 2